Craniopharyngioma clinical trials at UCSF

2 research studies open to eligible people

Showing trials for

  • FOG-001 in Locally Advanced or Metastatic Solid Tumors

    open to eligible people ages 18 years and up

    The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.

    San Francisco 5391959, California 5332921 and other locations

  • Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

    open to eligible people ages 1-39

    The current study assesses the tolerability and efficacy of monotherapy with pan-RAF-kinase (Tovorafenib) inhibition for the treatment of children and young adults with craniopharyngioma.

    San Francisco 5391959, California 5332921 and other locations

Last updated: